Biogen Said It is Updating the Label on Its Alzheimer's Disease Drug After the FDA ... - Latest Tweet by Reuters

Biogen said it is updating the label on its Alzheimer's disease drug after the FDA approved changes to the product information. The new label says that treatment should be initiated in patients with mild cognitive impairment or mild dementia https://t.co/YBMOH2eXk0 pic.twitter.com/aTEpsYusGg— Reuters (@Reuters) July 8, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)